ShockWave Medical (SWAV -10.4%) is down on a 7x surge in volume in apparent response to a report from Cliffside Research that rates the stock a Strong Sell with a $23 (39% downside risk) price target citing its heady valuation and the expiration of the lockup period today.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.